THE ANTIFIBROTIC POTENTIAL OF RESVERATROL IN SCHISTOSOMA MANSONI -INFECTED MICE | ||||
Journal of the Egyptian Society of Parasitology | ||||
Article 1, Volume 48, Issue 1, April 2018, Page 1-13 PDF (976.94 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/jesp.2018.77012 | ||||
View on SCiNiTO | ||||
Authors | ||||
RASHA H. SOLIMAN1, 2; O. A. ISMAIL3; EMAN M. EL-HAMSHARY3; A. H. HOSSINI3 | ||||
1Department of Parasitology, Faculty of Medicine, Suez Canal University, Ismaillia, Egypt.+ | ||||
2Department of Parasitology, Faculty of Medicine, Taif University, Kingdom of Saudi Arabia. | ||||
3Department of Parasitology, Faculty of Medicine, Suez Canal University, Ismaillia, Egypt. | ||||
Abstract | ||||
Schistosoma mansoni infection continues to be one of the most serious parasitosis worldwide due to its debilitating effects, mainly hepatic fibrosis. The present study explored the antifibrotic effect of resveratrol (RSV), either alone or in combination with praziquantel, on the murine model of intestinal schistosomiasis. We performed two parallel experiments exploring the preventive and the curative effect of RSV on inflammation and fibrosis. Parasitological measurements (adult worm burden, oogram), biochemical (AST, ALT, hydroxyproline), histopathological and histobiochemical studies were performed. The results revealed that RSV has significant curative and preventive outcome on hepatic fibrosis and this effect is augmented when coupled with praziquantel. Other parasitological and biochemical parameters were enhanced as well. | ||||
Keywords | ||||
Schistosoma mansoni; fibrosis; Resveratrol; hydroxyproline; Immunohistochemistry | ||||
Statistics Article View: 153 PDF Download: 162 |
||||